These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32448609)

  • 21. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
    Dai L; He J; Liu Y; Byun J; Vivekanandan A; Pennathur S; Fan X; Lubman DM
    Proteomics; 2011 Dec; 11(23):4529-40. PubMed ID: 21932445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
    Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
    Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
    Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
    Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain tumor stem cells from an adenoid glioblastoma multiforme.
    Oka N; Soeda A; Noda S; Iwama T
    Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To the novel paradigm of proteome-based cell therapy of tumors: through comparative proteome mapping of tumor stem cells and tissue-specific stem cells of humans.
    Bryukhovetskiy A; Shevchenko V; Kovalev S; Chekhonin V; Baklaushev V; Bryukhovetskiy I; Zhukova M
    Cell Transplant; 2014; 23 Suppl 1():S151-70. PubMed ID: 25303679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
    Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
    J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.
    Volovetz J; Berezovsky AD; Alban T; Chen Y; Lauko A; Aranjuez GF; Burtscher A; Shibuya K; Silver DJ; Peterson J; Manor D; McDonald JA; Lathia JD
    Cell Death Dis; 2020 Feb; 11(2):152. PubMed ID: 32102991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
    Xu JP; Liu H; Bian XW; Chen JH; Zhou XD; Wu YZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):609-13. PubMed ID: 18070450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
    Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
    Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells.
    Okawa S; Gagrica S; Blin C; Ender C; Pollard SM; Krijgsveld J
    Stem Cells; 2017 Apr; 35(4):967-980. PubMed ID: 27870168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
    Jin J; Grigore F; Chen CC; Li M
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMO-CRISPR-mediated apoptosis in CD133-targeted cancer stem cells and tumor growth inhibition.
    Pandey S; Lee M; Lim J; Park S; Choung YH; Kim JE; Garg P; Chung JH
    J Control Release; 2023 May; 357():94-108. PubMed ID: 36931470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
    Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
    Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis.
    Gagliardi F; Narayanan A; Gallotti AL; Pieri V; Mazzoleni S; Cominelli M; Rezzola S; Corsini M; Brugnara G; Altabella L; Politi LS; Bacigaluppi M; Falini A; Castellano A; Ronca R; Poliani PL; Mortini P; Galli R
    Neurobiol Dis; 2020 Feb; 134():104705. PubMed ID: 31830525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.